ALX Oncology Holdings Inc (ALXO)
1.385
+0.10
(+7.36%)
USD |
NASDAQ |
Nov 22, 11:13
ALX Oncology Holdings Total Assets (Quarterly): 185.72M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 185.72M |
| June 30, 2024 | 214.62M |
| March 31, 2024 | 212.65M |
| December 31, 2023 | 242.55M |
| September 30, 2023 | 220.11M |
| June 30, 2023 | 245.93M |
| March 31, 2023 | 278.14M |
| December 31, 2022 | 306.49M |
| September 30, 2022 | 317.69M |
| June 30, 2022 | 346.02M |
| Date | Value |
|---|---|
| March 31, 2022 | 363.68M |
| December 31, 2021 | 380.18M |
| September 30, 2021 | 399.73M |
| June 30, 2021 | 421.29M |
| March 31, 2021 | 432.91M |
| December 31, 2020 | 436.05M |
| September 30, 2020 | 262.45M |
| June 30, 2020 | 103.11M |
| March 31, 2020 | 108.40M |
| December 31, 2019 | 10.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.68M
Minimum
Dec 2019
436.05M
Maximum
Dec 2020
274.42M
Average
270.29M
Median
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| Neurocrine Biosciences Inc | 3.535B |
| Eton Pharmaceuticals Inc | 35.84M |
| Verve Therapeutics Inc | 663.91M |
| Immuneering Corp | 68.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.91M |
| Shareholders Equity (Quarterly) | 136.81M |